Skip to main content
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Subscribe
Home
Articles
Latest Issue
Issue Archive
Special Issues
Supplements
Categories
Conference Correspondent
ASH 2023 - CLL
SABCS 2023 - HR+/HER2- MBC
Web Exclusives
All Web Exclusives
Interview with the Innovators
Rapid Reactions
FDA Oncology Update
Videos
Press Releases
Gastrointestinal Cancer Monthly Minutes
For Authors
Author Guidelines
Symptom Management Overview
Letters to the Editor Instructions
Join Our Peer Review
Submit a Manuscript
About
About JHOP
Contact Us
Editorial Policies
Peer-Review Process
About the Editors
Editorial Board
Editorial Process
Advertising Policy
Advertise
Case Reports
,
Lung Cancer
Third-Line Tyrosine Kinase Inhibitor Therapy Results in 16-Year Remission in a Patient with Stage IV Non–Small-Cell Lung Cancer
Carrie L. Barnhart, PharmD, BCOP, and David F. Christianson, MD
Read More
Lung Cancer
2022 Midyear Review: Non–Small-Cell Lung Cancer
Read More
Meeting Highlights
Online Only
AACR Highlights
,
Lung Cancer
First-Line Sotorasib Shows Long-Lasting Responses in Metastatic NSCLC with KRAS Mutation
Read More
FDA Oncology Update
,
Lung Cancer
,
Checkpoint Inhibitors
Opdivo plus Platinum-Based Chemotherapy FDA Approved as First Neoadjuvant Treatment in Early-Stage NSCLC
Read More
Lung Cancer
Severe Adverse Events from Immune Checkpoint Inhibitor Therapy a Rare Concerning Side Effect
Read More
Lung Cancer
KRASᴳ¹²ᶜ Mutation–Positive Advanced NSCLC
Read More
Lung Cancer
CodeBreaK 100 Trial Results Demonstrate Sotorasib Conveys Clinical Benefit Across NSCLC Patient Subgroups
Read More
Lung Cancer
NSAID Use with Immune Checkpoint Inhibitors Associated with Longer Overall Survival in NSCLC
Read More
Lung Cancer
The Effect of Various KRAS Mutations on NSCLC Susceptibility
Read More
Lung Cancer
Patterns of Biomarker Testing in Metastatic NSCLC in the Community Oncology Setting
Read More
1
2
3
4
Page 1 of 12
Results 1 - 10 of 114